Literature DB >> 23392113

Classic "broken cell" techniques and newer live cell methods for cell cycle assessment.

Lindsay Henderson1, Dante S Bortone, Curtis Lim, Alexander C Zambon.   

Abstract

Many common, important diseases are either caused or exacerbated by hyperactivation (e.g., cancer) or inactivation (e.g., heart failure) of the cell division cycle. A better understanding of the cell cycle is critical for interpreting numerous types of physiological changes in cells. Moreover, new insights into how to control it will facilitate new therapeutics for a variety of diseases and new avenues in regenerative medicine. The progression of cells through the four main phases of their division cycle [G(0)/G(1), S (DNA synthesis), G(2), and M (mitosis)] is a highly conserved process orchestrated by several pathways (e.g., transcription, phosphorylation, nuclear import/export, and protein ubiquitination) that coordinate a core cell cycle pathway. This core pathway can also receive inputs that are cell type and cell niche dependent. "Broken cell" methods (e.g., use of labeled nucleotide analogs) to assess for cell cycle activity have revealed important insights regarding the cell cycle but lack the ability to assess living cells in real time (longitudinal studies) and with single-cell resolution. Moreover, such methods often require cell synchronization, which can perturb the pathway under study. Live cell cycle sensors can be used at single-cell resolution in living cells, intact tissue, and whole animals. Use of these more recently available sensors has the potential to reveal physiologically relevant insights regarding the normal and perturbed cell division cycle.

Entities:  

Keywords:  analysis methods; cell cycle pathway; live cells; review; sensors

Mesh:

Year:  2013        PMID: 23392113      PMCID: PMC3651638          DOI: 10.1152/ajpcell.00006.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  122 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors: detection methods and activity measurements.

Authors:  Gavin Brooks
Journal:  Methods Mol Biol       Date:  2005

3.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

4.  The centrosome opens the way to mitosis.

Authors:  Renata Basto; Jonathon Pines
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

5.  Dormancy of mammary carcinoma after mastectomy.

Authors:  T G Karrison; D J Ferguson; P Meier
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

Review 6.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

7.  Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes.

Authors:  G Brooks; R A Poolman; C J McGill; J M Li
Journal:  J Mol Cell Cardiol       Date:  1997-08       Impact factor: 5.000

Review 8.  The cell cycle and cancer.

Authors:  Gareth H Williams; Kai Stoeber
Journal:  J Pathol       Date:  2011-10-28       Impact factor: 7.996

9.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 10.  Saccharomyces cerevisiae as a model system to study the response to anticancer agents.

Authors:  Renata Matuo; Fabrício G Sousa; Daniele G Soares; Diego Bonatto; Jenifer Saffi; Alexandre E Escargueil; Annette K Larsen; João Antonio Pêgas Henriques
Journal:  Cancer Chemother Pharmacol       Date:  2012-08-01       Impact factor: 3.333

View more
  6 in total

1.  Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression.

Authors:  Vince Kornél Grolmusz; Eszter Angéla Tóth; Kornélia Baghy; István Likó; Ottó Darvasi; Ilona Kovalszky; János Matkó; Károly Rácz; Attila Patócs
Journal:  BMC Genomics       Date:  2016-05-27       Impact factor: 3.969

2.  Hematopoietic stem and multipotent progenitor cells produce IL-17, IL-21 and other cytokines in response to TLR signals associated with late apoptotic products and augment memory Th17 and Tc17 cells in the bone marrow of normal and lupus mice.

Authors:  Ching-I Chen; Li Zhang; Syamal K Datta
Journal:  Clin Immunol       Date:  2015-10-28       Impact factor: 3.969

3.  Methods and sensors for functional genomic studies of cell-cycle transitions in single cells.

Authors:  Alexander C Zambon; Tom Hsu; Seunghee Erin Kim; Miranda Klinck; Jennifer Stowe; Lindsay M Henderson; Donald Singer; Leomar Patam; Curtis Lim; Andrew D McCulloch; Bing Hu; Anna I Hickerson
Journal:  Physiol Genomics       Date:  2020-08-31       Impact factor: 3.107

4.  Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.

Authors:  Young-Chae Kim; Congcong Chen; Eric C Bolton
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

5.  A circular RNA hsa_circ_0079929 inhibits tumor growth in hepatocellular carcinoma.

Authors:  Huifei Zheng; Tengfei Chen; Chang Li; Chun Xu; Cheng Ding; Jun Chen; Sheng Ju; Zhiwei Zhang; Zhipan Liang; Zihan Cui; Jun Zhao
Journal:  Cancer Manag Res       Date:  2019-01-03       Impact factor: 3.989

Review 6.  DNA Replication: From Radioisotopes to Click Chemistry.

Authors:  Anna Ligasová; Karel Koberna
Journal:  Molecules       Date:  2018-11-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.